Impact of "SI Kumbang" Gymnastic Exercise on Physical Performance and Immunity in the Elderly
1 other identifier
interventional
66
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate and compare the impact of SI Kumbang gymnastic exercise and Bugar Lansia gymnastic exercise programs on physical performance dan immunity in elderly. It will also learn about the safety of SI Kumbang gymnastic exercise. The main questions it aims to answer are:
- How does cardiorespiratory fitness differ between SI Kumbang and Bugar Lansia exercise?
- How does muscle strength differ between SI Kumbang and Bugar Lansia exercise?
- How does balance differ between SI Kumbang and Bugar Lansia exercise?
- How does physical activity differ between SI Kumbang and Bugar Lansia exercise?
- How do Caspase-1 and IL-18 inflammasomes differ between SI Kumbang and Bugar Lansia exercise? Researchers will compare SI Kumbang gymnastic exercise to a Bugar Lansia gymnastic exercise to see if SI Kumbang gymnastic exercise better than Bugar Lansia gymnastic exercise. Participants will:
- Do SI Kumbang gymnastic exercise or Bugar Lansia gymnastic exercise a within 3 times a week for 3 months.
- Visit the clinic twice for outcome assesment before and after intervention.
- Keep a diary of their symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedFirst Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedDecember 24, 2025
December 1, 2025
5 months
November 19, 2025
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Cardiorespiration endurance as Assessed by Six-Minute Walk Distance (6MWD)
The definition of Six Minute Walking Distance (6MWD) is a 15-meter walking test for 6 minutes which is one of the sub-maximal tests, namely O2 uptake and heart rate are linearly related to VO2max so that fitness can be predicted. During the exercise, respondents are not allowed to run and respondents are allowed to rest during the test. This is an appropriate method because it has been proven to be able to achieve the sub-maximal zone and aerobic zone in a person. The results taken are the distance traveled in meters (Six Minutes Walking Distance).
From enrollment to the end of treatment at 12 weeks.
Strength muscle as Assessed by handgrip JAMAR
A Jamar is a handheld dynamometer used to measure the maximal strength of the hand and forearm muscles through an isometric grip test. It assesses the strength of the muscles primarily responsible for closing the fingers and gripping, such as the forearm flexors. The test involves a standardized procedure, and the results are displayed on a dual scale in kilograms and pounds, often with a peak-hold needle to record the highest force achieved.
From enrollment to the end of treatment at 12 weeks.
Balance as Assessed by Short Physical Performance Battery (SPPB).
The Short Physical Performance Battery (SPPB) is an objective assessment tool used to evaluate the physical function of an older person's lower extremities. It is comprised of three simple tasks: a timed chair stand test, a timed gait speed test, and a standing balance test. The results from these tests are combined into a score from 0 (worst) to 12 (best), which is used to predict various health outcomes such as disability, hospitalization, and mortality.
From enrollment to the end of treatment at 12 weeks
Physical activity as Assessed by Physical Activity Scale for the Elderly (PASE).
The Physical Activity Scale for the Elderly (PASE) is a brief, self-report questionnaire that assesses the level of physical activity in adults aged 65 and older over a one-week period. It includes questions about frequency and duration of leisure, household, and work-related activities and can be administered through telephone, mail, or in-person interviews. Higher scores indicate a greater amount of physical activity.
From enrollment to the end of treatment at 12 weeks.
Immunity were inflammasome as Assessed by Caspase-1 and IL-18.
Caspase-1 is an enzyme that activates the proinflammatory cytokines interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) by processing them into their mature, active forms. This process is a key part of the body's inflammatory response to infections and stress.
From enrollment to the end of treatment at 12 weeks.
Study Arms (2)
SI Kumbang Gymnastic Exercise
EXPERIMENTALIntervention Group received SI Kumbang gymnastic exercise
Bugar Lansia Gymnastic Exercise
ACTIVE COMPARATORControlled Group received Bugar Lansia gymnastic exercise
Interventions
SI Kumbang Gymnastic Exercise with four-way leg movements with hand movements using barbell weights and medium-intensity music.
Bugar Lansia Gymnastic Exercise with one-way forward leg movements with hand movements without barbell weights with medium intensity music.
Eligibility Criteria
You may qualify if:
- Female participants
- Age of 60 to 70 years old.
- Categorized as pre-frail (FI-40 score \> 0.08 \< 0.25) or robust (FI-40 score ≤ 0.08)
- Body mass index (BMI) between 18.5 and 24.9.
- Diabetes mellitus (controlled glucose ≤ 120 mg/dL)
- Blood pressure (controlled blood tension ≤ 130/80 mmHg) without taking any drugs that affected heart rate.
You may not qualify if:
- Chronic heart or lung disease conditions
- Chronic conditions that cannot be reversed (e.g., cancer or chronic renal disease)
- Diabetes complications in the extremities
- Motor impairment (MMT \< 5)
- Knee pain
- Lower limb deformities (genu varus/valgus)
- Hand deformities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Muhammadiyah Jakarta
Jakarta, DKI Jakarta, 13220, Indonesia
Study Officials
- PRINCIPAL INVESTIGATOR
Umi Sjarqiah, Medical Doctor
University of Muhammadiyah Jakarta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 24, 2025
Study Start
April 1, 2025
Primary Completion
September 10, 2025
Study Completion
September 30, 2025
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share